Follistatin and activins in polycystic ovary syndrome: Relationship to metabolic and hormonal markers

Metabolism: Clinical and Experimental

Volumn 62, Issue 10, 2013, Pages 1394-1400

  Teede, Helena ^a,b   Ng, Sze ^a   Hedger, Mark ^a   Moran, Lisa ^a,c  

^a MONASH UNIVERSITY   (Australia)

^b Southern Health   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Activin; Follistatin; Polycystic ovary syndrome

Indexed keywords

ACTIVIN A; C REACTIVE PROTEIN; FOLLISTATIN; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; MYELOPID; TRIACYLGLYCEROL; ACTIVIN; BIOLOGICAL MARKER; HORMONE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MEAN ARTERIAL PRESSURE; NATIONAL HEALTH ORGANIZATION; OBESITY; OVARY POLYCYSTIC DISEASE; PHENOTYPE; PREMENOPAUSE; PRIORITY JOURNAL; ARTERIAL PRESSURE; METABOLISM; PHYSIOLOGY;

ACTIVINS; ADULT; ARTERIAL PRESSURE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; FEMALE; FOLLISTATIN; HORMONES; HUMANS; INSULIN; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; OBESITY; OVERWEIGHT; POLYCYSTIC OVARY SYNDROME; PREMENOPAUSE; TRIGLYCERIDES;

EID: 84884533678     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2013.05.003     Document Type: Article

References (39)

1. L.J. Moran, M.L. Misso, and R.A. Wild Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis Hum Reprod Update 16 4 2010 347 363
2. A.A. Deeks, M.E. Gibson-Helm, and E. Paul Is having polycystic ovary syndrome a predictor of poor psychological function including anxiety and depression? Hum Reprod 2011
3. H. Teede, A. Deeks, and L. Moran Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan BMC Med 8 2010 41
4. W.A. March, V.M. Moore, and K.J. Willson The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria Hum Reprod 25 2 2010 544 551
5. H.J. Teede, S.K. Hutchison, and S. Zoungas The management of insulin resistance in polycystic ovary syndrome Trends Endocrinol Metab 18 7 2007 273 279
6. J.M. Vink, S. Sadrzadeh, and C.B. Lambalk Heritability of polycystic ovary syndrome in a Dutch twin-family study J Clin Endocrinol Metab 91 6 2006 2100 2104
7. C. Meyer, B.P. McGrath, and H.J. Teede Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease J Clin Endocrinol Metab 90 10 2005 5711 5716
8. M.P. Hedger, W.R. Winnall, and D.J. Phillips The regulation and functions of activin and follistatin in inflammation and immunity Vitam Horm 85 2011 255 297
9. P.G. Knight, L. Satchell, and C. Glister Intra-ovarian roles of activins and inhibins Mol Cell Endocrinol 359 1-2 2012 53 65
10. T. Nakamura, K. Takio, and Y. Eto Activin-binding protein from rat ovary is follistatin Science 247 4944 1990 836 838
11. N. Ueno, N. Ling, and S.Y. Ying Isolation and partial characterization of follistatin: a single-chain Mr 35,000 monomeric protein that inhibits the release of follicle-stimulating hormone Proc Natl Acad Sci USA 84 23 1987 8282 8286
12. J.K. Findlay An update on the roles of inhibin, activin, and follistatin as local regulators of folliculogenesis Biol Reprod 48 1 1993 15 23
13. H. Meunier, C. Rivier, and R.M. Evans Gonadal and extragonadal expression of inhibin alpha, beta A, and beta B subunits in various tissues predicts diverse functions Proc Natl Acad Sci USA 85 1 1988 247 251
14. A. Sjoholm, and T. Nystrom Inflammation and the etiology of type 2 diabetes Diabetes Metab Res Rev 22 1 2006 4 10
15. K. Kozaki, M. Akishita, and M. Eto Role of activin-A and follistatin in foam cell formation of THP-1 macrophages Arterioscler Thromb Vasc Biol 17 11 1997 2389 2394
16. P. Florio, S. Luisi, and P. Marchetti Activin A stimulates insulin secretion in cultured human pancreatic islets J Endocrinol Invest 23 4 2000 231 234
17. L. Bonomi, M. Brown, and N. Ungerleider Activin B regulates islet composition and islet mass but not whole body glucose homeostasis or insulin sensitivity Am J Physiol Endocrinol Metab 303 2012 587 596
18. R. Watanabe, Z.P. Shen, and K. Tsuda Insulin gene is a target in activin receptor-like kinase 7 signaling pathway in pancreatic beta-cells Biochem Biophys Res Commun 377 3 2008 867 872
19. O. Hashimoto, and M. Funaba Activin in glucose metabolism Vitam Horm 85 2011 217 234
20. J.N. Flanagan, K. Linder, and N. Mejhert Role of follistatin in promoting adipogenesis in women J Clin Endocrinol Metab 94 8 2009 3003 3009
21. Y.Q. Zhang, M.M. Cleary, and Y. Si Inhibition of activin signaling induces pancreatic epithelial cell expansion and diminishes terminal differentiation of pancreatic beta-cells Diabetes 53 8 2004 2024 2033
22. R.J. Norman, C.R. Milner, and N.P. Groome Circulating follistatin concentrations are higher and activin concentrations are lower in polycystic ovarian syndrome Hum Reprod 16 4 2001 668 672
23. Z.J. Shen, X.P. Chen, and Y.G. Chen Inhibin B, activin A, and follistatin and the pathogenesis of polycystic ovary syndrome Int J Gynaecol Obstet 88 3 2005 336 337
24. G.F. Erickson, D.G. Chung, and A. Sit Follistatin concentrations in follicular fluid of normal and polycystic ovaries Hum Reprod 10 8 1995 2120 2124
25. M.J. Chen, H.F. Chen, and S.U. Chen The relationship between follistatin and chronic low-grade inflammation in women with polycystic ovary syndrome Fertil Steril 92 6 2009 2041 2044
26. M. Urbanek, R.S. Legro, and D.A. Driscoll Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin Proc Natl Acad Sci USA 96 15 1999 8573 8578
27. W.X. Liao, A.C. Roy, and S.C. Ng Preliminary investigation of follistatin gene mutations in women with polycystic ovary syndrome Mol Hum Reprod 6 7 2000 587 590
28. L.J. Moran, B.J. Strauss, and H.J. Teede Diabetes risk score in the diagnostic categories of polycystic ovary syndrome Fertil Steril 95 5 2011 1742 1748
29. L.J. Moran, S.K. Hutchison, and C. Meyer A comprehensive assessment of endothelial function in overweight women with and without polycystic ovary syndrome Clin Sci (Lond) 116 10 2009 761 770
30. T.M. Wolever, D.J. Jenkins, and A.L. Jenkins The glycemic index: methodology and clinical implications Am J Clin Nutr 54 5 1991 846 854
31. J. Lindstrom, and J. Tuomilehto The diabetes risk score: a practical tool to predict type 2 diabetes risk Diabetes Care 26 3 2003 725 731
32. P.G. Knight, S. Muttukrishna, and N.P. Groome Development and application of a two-site enzyme immunoassay for the determination of 'total' activin-A concentrations in serum and follicular fluid J Endocrinol 148 2 1996 267 279
33. H. Ludlow, D.J. Phillips, and M. Myers A new 'total' activin B enzyme-linked immunosorbent assay (ELISA): development and validation for human samples Clin Endocrinol (Oxf) 71 6 2009 867 873
34. T. Eldar-Geva, I.M. Spitz, and N.P. Groome Follistatin and activin A serum concentrations in obese and non-obese patients with polycystic ovary syndrome Hum Reprod 16 12 2001 2552 2556
35. L. Moran, and H. Teede Metabolic features of the reproductive phenotypes of polycystic ovary syndrome Hum Reprod Update 15 4 2009 477 488
36. L.M. Kettel, L.V. DePaolo, and A.J. Morales Circulating levels of follistatin from puberty to menopause Fertil Steril 65 3 1996 472 476
37. H. Wu, M. Wu, and Y. Chen Correlation between blood activin levels and disease severity in type 2 diabetes Exp Diabetes Res 2013 In press
38. Y.G. Chen, H.M. Lui, and S.L. Lin Regulation of cell proliferation, apoptosis, and carcinogenesis by activin Exp Biol Med 227 2 2002 75 87
39. M.A. Engelse, J.M. Neele, and T.A. van Achterberg Human activin-A is expressed in the atherosclerotic lesion and promotes the contractile phenotype of smooth muscle cells Circ Res 85 10 1999 931 939